Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Neth Heart J. 2010 Sep;18(9):408-15. doi: 10.1007/BF03091807.
Background. To improve acute myocardial infarction (AMI) care in the region 'Hollands-Midden' (the Netherlands), a standardised guideline-based care program was developed (MISSION!). This study aimed to evaluate the outcome of the pre-hospital part of the MISSION! program and to study potential differences in pre-hospital care between four areas of residency.Methods. Time-to-treatment delays, AMI risk profile, cardiac enzymes, hospital stay, in-hospital mortality, and pre-AMI medication was evaluated in consecutive AMI patients (n=863, 61±13years, 75% male) transferred to the Leiden University Medical Center for primary percutaneous coronary intervention (PCI).Results. Median time interval between onset of symptoms and arrival at the catheterisation laboratory was 150 (interquartile range [IQR] 101-280) minutes. The alert of emergency services to arrival at the hospital time was 48 (IQR 40-60) minutes and the door-to-catheterisation laboratory time was 23 (IQR 13-42) minutes. Despite significant regional differences in ambulance transportation times no difference in total time from onset of symptoms to arrival at the catheterisation room was found. Peak troponin T was 3.33 (IQR 1.23-7.04) μg/l, hospital stay was 2 (IQR 2-3) days and in-hospital mortality was 2.3%. Twelve percent had 0 known risk factors, 30% had one risk factor, 45% two to three risk factors and 13% had four or more risk factors. No significant differences were observed for AMI risk profiles and medication pre-AMI. Conclusions. This study shows that a standardised regional AMI treatment protocol achieved optimal and uniformly distributed pre-hospital performance in the region 'Hollands-Midden', resulting in minimal time delays regardless of area of residence. Hospital stay was short and in-hospital mortality low. Of the patients, 88% had ≥1 modifiable risk factor. (Neth Heart J 2010;18:408-15.).
为了改善荷兰“霍兰兹米登”地区的急性心肌梗死(AMI)治疗水平,开发了一种标准化的基于指南的治疗方案(MISSION!)。本研究旨在评估 MISSION!项目的院前部分的结果,并研究四个居住区域之间的院前护理差异。
连续评估了 863 名(61±13 岁,75%为男性)接受直接经皮冠状动脉介入治疗(PCI)的 AMI 患者的治疗延迟时间、AMI 风险状况、心肌酶、住院时间、院内死亡率和 AMI 前用药。
症状发作与到达导管室之间的中位时间间隔为 150 分钟(IQR 101-280)。急救服务发出警报至到达医院的时间为 48 分钟(IQR 40-60),门到导管室的时间为 23 分钟(IQR 13-42)。尽管在救护车转运时间方面存在显著的区域差异,但从症状发作到到达导管室的总时间没有差异。肌钙蛋白 T 峰值为 3.33(IQR 1.23-7.04)μg/l,住院时间为 2 天(IQR 2-3),院内死亡率为 2.3%。12%的患者无已知危险因素,30%的患者有一个危险因素,45%的患者有两个至三个危险因素,13%的患者有四个或更多危险因素。AMI 风险状况和 AMI 前用药未见明显差异。
本研究表明,标准化的区域 AMI 治疗方案在“霍兰兹米登”地区实现了最佳和均匀的院前表现,无论居住区域如何,都能将时间延迟降到最低。住院时间短,院内死亡率低。88%的患者有≥1 个可改变的危险因素。